Prestige Consumer Healthcare Operating Margin 2010-2024 | PBH
Current and historical operating margin for Prestige Consumer Healthcare (PBH) over the last 10 years. The current operating profit margin for Prestige Consumer Healthcare as of December 31, 2024 is 18.95%.
| Prestige Consumer Healthcare Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2024-12-31 |
$1.12B |
$0.33B |
29.52% |
| 2024-09-30 |
$1.11B |
$0.33B |
29.25% |
| 2024-06-30 |
$1.11B |
$0.33B |
29.56% |
| 2024-03-31 |
$1.13B |
$0.34B |
30.40% |
| 2023-12-31 |
$1.13B |
$-0.02B |
-1.85% |
| 2023-09-30 |
$1.13B |
$-0.02B |
-1.86% |
| 2023-06-30 |
$1.13B |
$-0.03B |
-2.21% |
| 2023-03-31 |
$1.13B |
$-0.02B |
-2.04% |
| 2022-12-31 |
$1.11B |
$0.34B |
30.21% |
| 2022-09-30 |
$1.11B |
$0.33B |
29.90% |
| 2022-06-30 |
$1.09B |
$0.33B |
29.80% |
| 2022-03-31 |
$1.09B |
$0.33B |
30.39% |
| 2021-12-31 |
$1.06B |
$0.32B |
30.65% |
| 2021-09-30 |
$1.02B |
$0.31B |
30.72% |
| 2021-06-30 |
$0.98B |
$0.31B |
31.33% |
| 2021-03-31 |
$0.94B |
$0.30B |
31.50% |
| 2020-12-31 |
$0.96B |
$0.30B |
31.38% |
| 2020-09-30 |
$0.96B |
$0.30B |
31.60% |
| 2020-06-30 |
$0.96B |
$0.30B |
31.15% |
| 2020-03-31 |
$0.96B |
$0.29B |
30.11% |
| 2019-12-31 |
$0.95B |
$0.06B |
6.61% |
| 2019-09-30 |
$0.95B |
$0.07B |
6.83% |
| 2019-06-30 |
$0.95B |
$0.07B |
7.03% |
| 2019-03-31 |
$0.98B |
$0.07B |
6.97% |
| 2018-12-31 |
$0.99B |
$0.20B |
20.00% |
| 2018-09-30 |
$1.02B |
$0.20B |
20.00% |
| 2018-06-30 |
$1.04B |
$0.21B |
20.12% |
| 2018-03-31 |
$1.04B |
$0.22B |
20.73% |
| 2017-12-31 |
$1.03B |
$0.29B |
28.43% |
| 2017-09-30 |
$0.97B |
$0.28B |
28.47% |
| 2017-06-30 |
$0.93B |
$0.27B |
29.25% |
| 2017-03-31 |
$0.88B |
$0.21B |
23.22% |
| 2016-12-31 |
$0.85B |
$0.22B |
25.53% |
| 2016-09-30 |
$0.83B |
$0.21B |
25.33% |
| 2016-06-30 |
$0.82B |
$0.21B |
25.49% |
| 2016-03-31 |
$0.81B |
$0.26B |
32.38% |
| 2015-12-31 |
$0.79B |
$0.26B |
32.61% |
| 2015-09-30 |
$0.79B |
$0.25B |
31.93% |
| 2015-06-30 |
$0.76B |
$0.23B |
29.96% |
| 2015-03-31 |
$0.72B |
$0.21B |
29.09% |
| 2014-12-31 |
$0.67B |
$0.19B |
28.74% |
| 2014-09-30 |
$0.62B |
$0.18B |
28.46% |
| 2014-06-30 |
$0.60B |
$0.18B |
30.28% |
| 2014-03-31 |
$0.60B |
$0.19B |
31.44% |
| 2013-12-31 |
$0.61B |
$0.19B |
31.85% |
| 2013-09-30 |
$0.62B |
$0.20B |
32.21% |
| 2013-06-30 |
$0.62B |
$0.20B |
31.98% |
| 2013-03-31 |
$0.62B |
$0.19B |
30.97% |
| 2012-12-31 |
$0.60B |
$0.17B |
27.36% |
| 2012-09-30 |
$0.55B |
$0.14B |
25.87% |
| 2012-06-30 |
$0.49B |
$0.12B |
24.34% |
| 2012-03-31 |
$0.44B |
$0.10B |
23.36% |
| 2011-12-31 |
$0.40B |
$0.10B |
24.57% |
| 2011-09-30 |
$0.39B |
$0.09B |
22.68% |
| 2011-06-30 |
$0.36B |
$0.08B |
23.06% |
| 2011-03-31 |
$0.34B |
$0.08B |
22.92% |
| 2010-12-31 |
$0.31B |
$0.08B |
24.43% |
| 2010-09-30 |
$0.29B |
$0.09B |
29.31% |
| 2010-06-30 |
$0.29B |
$0.08B |
27.65% |
| 2010-03-31 |
$0.29B |
$0.08B |
26.96% |
| 2009-12-31 |
$0.28B |
$-0.17B |
-60.42% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$4.171B |
$1.125B |
|
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.
|
